CIBC Bancorp USA’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$467K Buy
7,987
+745
+10% +$41.5K ﹤0.01% 1414
2026
Q2
$394K Buy
7,242
+1,297
+22% +$63.1K ﹤0.01% 1397
2026
Q1
$258K Buy
+5,945
New +$256K ﹤0.01% 1484

Other funds holding EXEL

CIBC Bancorp USA's EXEL Position: Q3 2026 in Review

CIBC Bancorp USA increased its Exelixis (EXEL) stake by 10% in Q3 2026, buying an estimated $41.5K and bringing the position to 7,987 shares worth $467K. The position accounts for ﹤0.01% of the portfolio, ranked #1414.

CIBC Bancorp USA first reported a position in EXEL in Q1 2026 and has held it in 3 quarters since. 637 funds tracked by Wall St. Rank hold EXEL as of Q3 2026.

  • CIBC Bancorp USA held 7,987 shares of Exelixis worth $467K as of Q3 2026.
  • CIBC Bancorp USA bought 745 Exelixis shares in Q3 2026, an estimated $41.5K.
  • Exelixis made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1414 holding.
  • CIBC Bancorp USA first reported a position in Exelixis in Q1 2026 and has held it in 3 quarters since.
  • 637 funds tracked by Wall St. Rank held Exelixis as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.